• Glioblastoma Vulnerability to BCL-2 Family BH3-Mimetics

  2026-08-18

  Koessinger and colleagues show that glioblastoma, including stem-like tumor-cell populations, has heightened dependence on the anti-apoptotic proteins BCL-XL and MCL-1. Their study links this apoptotic priming to therapeutic sensitivity and demonstrates that sequential targeting of both survival proteins can produce robust antitumor responses in vivo.

• SU 5402: Reliable Assay Design in RTK Biology

  2026-08-18

  A practical, scenario-based guide to using SU 5402 (SKU A3843) in viability, proliferation, cytotoxicity, and receptor tyrosine kinase experiments. It connects product specifications with controls, dosing logic, storage, and interpretation limits for cancer and human neuron research.

• BCL-XL inhibitor A-1155463: Research Workflows

  2026-08-17

  A-1155463 is a selective BCL-XL inhibitor for linking target engagement to mitochondrial apoptosis, resistance biology, and tumor-model response. This practical guide covers solvent handling, dose-response design, apoptosis validation, model selection, and troubleshooting across solid-tumor and hematological research.

• JSH-23 Workflows for NF-κB Signaling Studies

  2026-08-17

  JSH-23 is a mechanistically focused NF-κB inhibitor for separating p65-dependent transcription from upstream IκB degradation. This guide translates that distinction into practical macrophage, airway-epithelial, and cisplatin-induced kidney injury workflows, with concentration, assay, and troubleshooting recommendations.

• How FASN Controls Mitochondrial Apoptotic Priming

  2026-08-16

  Schroeder and colleagues show that fatty acid synthase (FASN) inhibition is not only a metabolic intervention: it increases mitochondrial apoptotic priming through BH3-only proteins and redox stress. This mechanism explains why FASN blockade can synergize with ABT-263 (Navitoclax) and venetoclax in breast cancer models, offering a framework for biomarker-guided combination studies.

• TRPV1+ Nerve Stimulation and the Somato-Autonomic Reflex

  2026-08-15

  Song et al. show that stimulating TRPV1+ peripheral afferents at the nape can suppress systemic inflammation through coordinated brainstem, endocrine, sympathetic, vagal, and splenic pathways. The study provides a mechanistic framework for region-specific neuroimmune intervention while also defining important limits for translation beyond the reported experimental models.

• HotStart Universal 2X Green qPCR Master Mix Workflow

  2026-08-14

  Build a reproducible dye-based qPCR workflow for fusion-transcript studies, including FGFR2-AHCYL1 assays inspired by recent cholangiocarcinoma research. The guide combines practical setup parameters, melt-curve specificity checks, normalization strategies, and troubleshooting for dependable gene expression quantification.

• A-1210477 MCL-1 Apoptosis Workflow

  2026-08-14

  A-1210477 is a selective MCL-1 inhibitor for testing how MCL-1-dependent cancer cells resist mitochondrial apoptosis. This practical guide covers compound handling, dose-response design, BAX/BAK-aware validation, combination studies, and troubleshooting while keeping its in vitro scope distinct from in vivo claims.

• SAN-Plexus Assembloids Model Pacemaker Maturation

  2026-08-13

  This study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like organoids to model neural regulation of pacemaker maturation. By integrating electrophysiology with human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 signaling program linking cardiac neurons to pacemaker-cell development and conduction function.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-13

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent Western blot assays. It is intended for HRP-labeled immunoblots and film or CCD imaging, not for fluorescent or radioisotopic detection workflows.

• ABT-263: From Apoptosis to Senescence Biology

  2026-08-12

  ABT-263 (Navitoclax) is more than a Bcl-2-family inhibitor: it is a translational probe for testing how mitochondrial survival dependence shapes apoptosis, senescence, fibrosis, and therapeutic response across disease models.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-12

  Shen et al. identify a mechanistic link between protein phosphatase 2A, autophagy-related protein phosphorylation, and drug resistance in Candida albicans biofilms. Their combination of PPH21 genetic disruption, rapamycin-mediated autophagy activation, and an oral infection model suggests that the PP2A–Atg13–Atg1 axis is a potential target for studying biofilm-associated antifungal failure.

• Annexin V-PE Reagent in CD38 CAR-T Assays

  2026-08-11

  Use Annexin V-PE Reagent to quantify phosphatidylserine externalization in CD38 CAR-T co-cultures, separating target-cell killing from possible effector-cell fratricide. The one-step, 15–30-minute workflow supports both flow cytometry and fluorescence microscopy for rapid apoptosis profiling during binder optimization.

• ABT-199 (Venetoclax) Workflow for Apoptosis Assays

  2026-08-11

  Build more informative apoptosis experiments with ABT-199 (Venetoclax), a selective BCL-2 probe for mapping mitochondrial dependence in lymphoma, AML, and senescence models. This practical guide combines dose-response design, time-resolved readouts, combination testing, and troubleshooting for more reproducible results.

• Resiniferatoxin (RTX): TRPV1 Analgesia

  2026-08-10

  Resiniferatoxin (RTX) is an ultra-potent TRPV1 agonist that converts selective channel activation into prolonged desensitization of pain-sensing afferents. Its research value spans neuropathic pain, osteoarthritis pain, neurogenic inflammation, and route-specific sensory-neuron studies.

16393 records 1/1093 page Next 12345 下5页 Last page